Intercept Blood System for Platelets
Device Device-Transfusion
PDI 18717953196955
General payments
$1,314,631
Research payments
$11,964,418
Through program year 2025, $1,314,631 in general payments and $11,964,418 in research payments were reported against Intercept Blood System for Platelets (Device-Transfusion).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $714,176 | 423 |
| 2025 | Research | $1,988,075 | 77 |
| 2024 | General | $293,229 | 319 |
| 2024 | Research | $1,617,482 | 88 |
| 2023 | General | $177,409 | 338 |
| 2023 | Research | $2,970,334 | 121 |
| 2022 | General | $84,580 | 69 |
| 2022 | Research | $2,524,890 | 107 |
| 2021 | General | $45,236 | 22 |
| 2021 | Research | $2,863,637 | 138 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,171 general · 531 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.